The global meningitis diagnosis and treatment market is expected to grow at a CAGR of 5.2% during the forecast period.
Inflammation of meninges is known as meningitis, which is of three types, viral, bacterial, and fungal. Viral and bacterial meningitis are found to be common across the globe. Bacterial meningitis is known to be life-threatening, if not treated at an early stage. Delayed treatment may lead to a risk of permanent brain damage or death. Devices such as MRI, CT, and X-rays are used for the diagnosis of meningitis. It can be treated by administration of antibiotics and adjunctive therapy. Therefore, early diagnosis and treatment of meningitis play a major in managing meningitis.
The focus of research on neurology and the increasing emphasis on early diagnosis are the major drivers for the market growth. Additionally, availability of advanced diagnostic systems also fuels the market growth.
Some of the key players in the global market are Thermo Fisher Scientific, Inc., BioFire Diagnostics, Siemens, Quest Diagnostics, Bio-Rad Laboratories, Inc., Luminex Corporation, Seegene Inc., IMMY, ELITechGroup, Abbott, Pfizer, Nuron Biotech, GSK, MedImmune, Sanofi, Novartis, Baxter, Merck & Co., Biomed Pvt. Ltd, and others.
America is the largest market for meningitis diagnosis and treatment, with North America holding the maximum share. The North American market is driven by the extensive growth of the medical device sector with a concentration of major market players and the emergence of new technologies in the market. Awareness about neurological disorders and diagnosis is found to be increasing among the U.S. population, which further fuels the growth of the market.
In Europe, Germany and France are the major contributors to the market growth, which is attributed to an increase in spending on the research and development activities and huge investments in healthcare by European countries.
The Asia Pacific market is expected to show growth with the increasing use of MRI and CT imaging technologies for diagnosis of brain disorders and the rising government incentives for research and diagnosis and treatment services. India, China, and Japan are the major contributors to the growth of the market.
In the Middle East & Africa, the market is driven by increasing prevalence of meningitis and the rising demand for diagnosis and treatment services for neurological disorders.
Browse Complete Report at  .
The global meningitis diagnosis and treatment market is segmented on the basis of type, diagnosis, treatment, and end-user.
On the basis of type, the market is segmented into bacterial, fungal, and viral infections.
On the basis of diagnosis, the market is segmented into blood culture, imaging, and lumbar puncture. Imaging is further segmented into MRI, CT, and X-ray.
On the basis of treatment, the market is segmented into antibiotics and adjunctive therapy.
On the basis of end-user, the market is segmented into hospitals and clinics, surgical centers, and others.